I must be one of the few geeks it looks like about 5 people in the audience right now!
I've been in and out (mostly out) caught some of the tail end of the FDA talk had some interesting discussion may try to catch all of this segment in replay. Were talking about the process and meetings, disclosure policy, etc. Didn't hear anything earth shattering but good to know things as told by FDA and not company line or message board rumor .